Using this platform [20], we previously showed that the CCK-BR targeted NP could deliver siRNA to orthotopic pancreatic tumors in mice to downregulate gastrin, as gastrin peptide stimulates growth of pancreatic cancer [23,24] whereas, the untargeted NP had no effect. Here, GAST is linked to pancreatic neoplasm.